"The approach accelerates blood clearance and reduces bone marrow residence time compared with standard monoclonal antibodies (mAbs), while retaining target selectivity, internalisation and retention."
Phase 1/2 of TLX592 Targeted Alpha Th... - Advanced Prostate...
Phase 1/2 of TLX592 Targeted Alpha Therapy in Prostate Cancer starting soon - Ac 225
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
We need best delivery system for Ac 225 so stay in body longer time and kill the cancer cell
indeed but preserving bone marrow
Not what you're looking for?
You may also like...
Highly effective targeted therapy for metastatic prostate cancer, using 177Lu-PSMA Radioligand
Lutetium 177 (Lu).
LU 177 PSMA therapy or Prostate-Specific Membrane Antigen Therapy, reduces the...
Study reports direct targets of ivermectin in prostate cancer
reveals FOXA1 and Ku70/Ku80 as direct targets of ivermectin in prostate cancer
Shidong Lv, Zeyu...
Targeting a single enzyme can kill prostate cancer cells
news-medical.net/amp/news/20230203/Targeting-a-single-enzyme-can-kill-prostate-cancer-cells.aspx...
Anti-Androgen Therapy and Bone Tumors in Prostate Cancer
will help us to better target treatments for men with different types of prostate cancer,” he said....
Long term AR signaling‐targeted therapy with taxane sometimes associated with visceral metastasis in castration‐resistant prostate cancer
The present study was conducted to present androgen receptor signaling‐targeted therapy and taxane...
Avoiding radiation damage to salivary glands with Ac-225-PSMA-617 therapy
Revisiting Intermittent Therapy in Metastatic Prostate Cancer
PI5P4Kα - targeting single enzyme kills prostate cancer?
Prostate Cancer Therapy:
Prostate cancer has returned, considering experimental therapy (if I can get it).
